Retrieved from NovoCare-c
Effective contamination control strategies facilitating axenic cultivation of Haematococcus pluvialis : risks and challenges
Business Type Manufacturer, Service Provider, Supplier Employee Count 55 Establishment 1984 Working Days To GST NO 24AADCT0969P1ZT Payment Mode Others Related Products Explore Related Categories More Products From This Seller Seller Details GST - 24AADCT0969P1ZT Trusted Seller Ahmedabad, Gujarat Director Mr Amit Kumar Vadhiya Members since 2 Years Address 3008, G.I.D.C Phase IV, Vatva, Ahmedabad, Gujarat, 382445, India Report incorrect details
Every batch is HPLC-tested to confirm a purity of 99%, consistent with its GLP-1/GIP/GCGR triple-agonist profile (CAS number 2381089-83-2)
Summary GLP-1 medicines such as Ozempic, Wegovy and Mounjaro can be effective treatments for overweight and obesity
The research language also bluntly portrays a long-term journey, with the meta-analysis authors positing that weight regain is common and drug-dependent following the discontinuation of anti-obesity pharmacotherapies. And in December 2025, the WHO issued its first-ever guideline on GLP-1 therapies for obesity, explicitly framing obesity as a chronic disease requiring "comprehensive and lifelong care, recommending GLP-1 therapies for long-term use